Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Compass Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get CMPX alerts

About Vered Bisker-Leib, PhD

Vered Bisker-Leib, PhD is recorded as CEO and Board Member at Compass Therapeutics, Inc. (CMPX) since January 9, 2024. Compass Therapeutics, Inc. reported in an 8-K filed January 9, 2024 that Vered Bisker-Leib, PhD was appointed member of the Board, effective January 9, 2024. Compass Therapeutics, Inc. reported in an 8-K filed January 9, 2024 that Vered Bisker-Leib, PhD was appointed Chief Executive Officer, effective January 9, 2024. Compass Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Compass Therapeutics, Inc. includes Thomas J. Schuetz (CEO and Board Member), Thomas Schuetz (CEO and Board Member), Thomas Schuetz, MD, PhD (CEO and Chairman) and 7 others.

“on January 8, 2024, the Board of Directors (the "Board") of Compass Therapeutics, Inc. (the "Company") appointed Vered Bisker-Leib, PhD as Chief Executive Officer of the Company and a member the Board, each effective January 9, 2024.”
Compass Therapeutics, Inc. Form 8-K, filed January 9, 2024 · Read the filing
“on January 8, 2024, the Board of Directors (the "Board") of Compass Therapeutics, Inc. (the "Company") appointed Vered Bisker-Leib, PhD as Chief Executive Officer of the Company and a member the Board, each effective January 9, 2024.”
Compass Therapeutics, Inc. Form 8-K, filed January 9, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Compass Therapeutics, Inc.

Recent activity